Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000465829 | SCV000558484 | benign | Brugada syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704572 | SCV000714247 | likely benign | not provided | 2020-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704572 | SCV002585973 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SCN10A: BP4, BP7 |
Ambry Genetics | RCV002329118 | SCV002629173 | likely benign | Cardiovascular phenotype | 2019-03-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002489112 | SCV002803054 | likely benign | Episodic pain syndrome, familial, 2 | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000611774 | SCV001922703 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001704572 | SCV001953962 | likely benign | not provided | no assertion criteria provided | clinical testing |